Biotech Responds to Dramatic Changes to Innovate in 2010 and Beyond

Overview:

A series of articles include 'Partners in Survival: Biotech executives respond to the dramatic changes in the world,' 'The Year that Wasn’t: Even when raising money is hard, having a revenue-generating business can ensure longevity,' and '10 Fellow Travelers: Big Pharma’s move toward targeted therapeutics is fueling dealmaking between drug and diagnostics companies.'